Publications Archive - 2013

Recent Posts

I Blame Gwyneth

  • 23 December 2013

Commercialization and Stem Cell Research: A Review of Emerging Issues

  • 20 December 2013

Angelina Jolie's faulty gene: newspaper coverage of a celebrity's preventive bilateral mastectomy in Canada, the United States, and the United Kingdom

  • 19 December 2013

Reflections on Perceptions of Promise: Biotechnology, Society and Art

  • 19 December 2013

Naturopaths and the creep of pseudo-­science

  • 15 December 2013

The global landscape of stem cell clinical trials

  • 18 November 2013

Reflections on the Cost of "Low-Cost" Whole Genome Sequencing: Framing the Health Policy Debate

  • 05 November 2013

Policy Options: Time to encourage organ donation

  • 01 November 2013

CNTRP Fast Policy Facts

  • 04 October 2013

A Role for Patient Advocacy Groups in Countering the Premature Commercialization of Stem Cell Interventions

  • 01 October 2013

"Is a cure in my sight?" Multi-stakeholder perspectives on phase I choroideremia gene transfer clinical trials

  • 26 September 2013

Section 8 of the Charter: Cost-benefit Analysis in Constitutional Interpretation

  • 04 September 2013

Irresistible Impulse and the Mental Disorder Defence: the Criminal Code, the Charter, and the Neuroscience of Control

  • Steven Penney
  • 04 September 2013

Policy Options: The Paradoxes of Pop Science

  • 01 September 2013

The Increasing Involvement of Physicians in Complementary and Alternative Medicine: Considerations of Professional Regulation and Patient Safety

  • 01 September 2013

Informed Consent and Patient Comprehension: The Law and the Evidence

  • Sarah Burningham, Christen Rachul and Timothy Caulfield
  • 29 August 2013

What Is the Role of Regulation in the Management and Prevention of Obesity?

  • 27 August 2013

Policy Uncertainty, Sequencing, and Cell Lines

  • 01 August 2013

Public Health Law & Policy in Canada, 3rd Edition

  • Nola M Ries, Tracey Bailey, Timothy Caulfield
  • 31 July 2013

Law, Policy and Reproductive Autonomy

  • 01 July 2013

Incidental Findings in the Era of Whole Genome Sequencing?

  • Erik Parens, Paul Appelbaum and Wendy Chung
  • 01 July 2013

Direct-to-consumer genetic testing - where should we focus the policy debate?

  • 20 May 2013

When Pictures Waste a Thousand Words: Analysis of the 2009 H1N1 Pandemic on Television News.

  • 17 May 2013

Ethics and Genomic Incidental Findings

  • 16 May 2013

The American College of Medical Genetics and Genomics (ACMG) recently issued a statement (1) recommending that all laboratories conducting clinical sequencing seek and report pathogenic and expected pathogenic mutations for a short list of carefully chosen genes and conditions....

Patents and misplaced Angst: lessons for translational stem cell research from genomics.

  • 02 May 2013

Reassessing direct-to-consumer portrayals of unproven stem cell therapies: is it getting better?

  • Ogbogu,U, Rachul,C, and Caulfield,T
  • 01 May 2013

Aim: To determine whether increased scrutiny of 'stem cell tourism' has resulted in changes to online claims by clinics that provide putative unproven stem cell treatments. Materials & methods: We analyzed historical and current versions of clinics' websites. The study sample consisted of 18 websites included in a 2008 peer-reviewed study and an additional 12 clinics identified through the Google™ search engine...

The Assisted Human Reproduction Act Reference and the Thin Line Between Health and Crime

  • Obgogu,U
  • 26 April 2013

When should health be treated as a subject of criminal law? With respect to health, the Constitution Act, 18671 does not specifically assign legislative authority to any level of government.2 As a result, Parliament and provincial legislatures can enact laws relating to health...

What's Missing? Discussing Stem Cell Translational Research in Educational Information on Stem Cell "Tourism"

  • Master,Z Rachul,C and Caulfield,T
  • 12 April 2013

Global trade and assisted reproductive technologies: regulatory challenges in international surrogacy.

  • 01 April 2013

Incorporating Exclusion Clauses into Informed Consent for Biobanking

  • 01 April 2013

Patent landscaping for life sciences innovation: toward consistent and transparent practices.

  • 31 March 2013

Policies and Initiatives Aimed at Addressing Research Misconduct in High-Income Countries

  • 26 March 2013

Harm, hype and evidence: ELSI research and policy guidance

  • 26 March 2013

Cell therapy research and innovation: Identifying the emerging privacy challenges

  • Burningham, S
  • 25 March 2013

Cancer Patient Perceptions on the Ethical and Legal Issues Related to Biobanking

  • 08 March 2013

Position Statement on the Provision and Procurement of Human Eggs for Stem Cell Research

  • 07 March 2013

Commentary: the law, unproven CAM and the referral challenge

  • Caulfield,T, Ogbogu,U and Robertson,G
  • 01 March 2013

Pharmaceutical care and access to health information decisions involving minors: Characterizing the pharmacist's obligation to the patient

  • Ogbogu,U and Morton,S
  • 01 March 2013

Restricting marketing to children: Consensus on policy interventions to address obesity

  • Raine,K; Lobstein,R; Landonc,J; Potvin Kent,M; Pellerin,S; Caulfield,T; Finegood,D; Mongeau,L; Neary,N and Spence,J
  • 28 February 2013

Newspaper portrayals of spinal manipulation therapy: Canada, United States, and the United Kingdom

  • Rachul, C, Boon, H and Caulfield, T
  • 27 February 2013

Media, politics and science policy: MS and evidence from the CCSVI Trenches

  • 12 February 2013

2012 Highlights in Translational 'Omics

  • 31 January 2013

Using and Abusing Evidence in Science and Health Policy

  • 31 January 2013

The false promise of false science: Homeopathy as pseudoscience

  • Caulfield,T
  • 21 January 2013

Chinese Newspaper Coverage of (Unproven) Stem Cell Therapies and their Providers

  • Ogbogu,U; Du,L; Rachul,C; Bélanger,L and Caulfield, T
  • 06 January 2013

Quacks and Conspiracies

  • 01 January 2013

Cancer patients perceptions on the ethical and legal issues related to biobanking

  • 01 January 2013

Promoting Public Trust: ESCROs Won't Fix the Problem of Stem Cell Tourism

  • 01 January 2013

Getting Closer to a Fully Correctable and Connected Research Literature

  • 01 January 2013

Incorporating Exclusion Clauses into Informed Consent for Biobanking

  • Master, Z and Resnick, D
  • 01 January 2013

Archive